Reason for request
Reassessment of the IAB.
Clinical Benefit
| Substantial |
Le service médical rendu par ces spécialités reste important.
|
Clinical Added Value
| minor |
la Commission maintient l'ASMR IV attribuée le 2 juin 2004 à RISPERDALCONSTA en tant que modalité d'administration susceptible d'améliorer la prise en charge de ces patients.
|
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
01YtVTajt7ttX1et
